BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Nearly 3 weeks post FDA approval and CR with no further...

  1. 803 Posts.
    lightbulb Created with Sketch. 290
    Nearly 3 weeks post FDA approval and CR with no further announcements- not a word from the company. I was crowing from the rooftops that there should be a 12 month backlog of announcements at the ready but were constrained until approval!

    It is apparent that the posturing during the commercial day webinar may be just that! posturing. . . Nothing has been added to the depth of the claims except 233 million extra shares on issue!

    This webinar has the same posturing as BB at a mining conference in London! Those of you that understand this last paragraph have been around awhile - If you know, you know

    @Beefarmer
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.